The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects

Br J Cancer. 1982 May;45(5):655-69. doi: 10.1038/bjc.1982.106.


Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 treatment groups ("watch policy" and radiotherapy) but patients in the WP group whose tumours were of Grade II or III or greater than 2 cm, or with lymph-node metastases, had a greater chance of local recurrence. Cellular reaction had no relationship with prognosis, except in patients with Grade III tumours. The clinical relevance and application of these results are discussed.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Breast Neoplasms / immunology
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / radiotherapy
  • Clinical Trials as Topic
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Mitosis
  • Neoplasm Recurrence, Local
  • Prognosis